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A hypothesis for the pathobiochemical mechanism of CO poisoning, amenable to in vivo testing with optical reflectance spectrophotometry, is 
presented. It differs from the classical formulation in which loss of cytochrome coxidase function is attributed entirely to 0, depletion, by including 
ligation and oxygenation of CO as essential components of the inhibitory process. 
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1. INTRODUCTION 
Except for two recent refinements, the intravascular 
component of J.S. Haldane’s hypothesis [l] has with- 
stood the test of time. Thin-layer optical measurements 
[2] have shown that the carboxyhemoglobin (HbCO) 
and oxyhemoglobin (HbO2) saturation curves are not 
parallel (see also [3,4]) and that binding of CO to Hb is 
more cooperative than for 02. Thus, Haldane’s laws 
I%HbCO/%HbOz =M (the Haldane constant) xpd 
p02 and %HbCO + %HbOz =jiIpoz + Mxpco)] are 
valid only at total saturation (T= number of occupied 
binding sites = 4). Quantitation of incompletely 
saturated forms present during ligation of CO and 02 to 
Hb [5] shows that the CO-induced left shift of the HbO2 
dissociation curve (seen but not explained by Haldane) 
is due to bound CO promoting 02 ligation at low partial 
pressures of 02. Although some controversy [6-91 sur- 
rounds the idea that the CO-induced left shift and fun- 
cational anemia (the latter a result of the slow dissocia- 
tion of CO from HbCO [lo]) produce cellular hypoxia, 
the weight of evidence favors this viewpoint. In con- 
tradistinction to Haldane, we believe that CO can bind 
to tissue cytochromes during CO intoxication, but do 
not subscribe the idea that this reaction is the sole 
reason for its toxicity. 
J.B.S. Haldane was the first to provide evidence for 
an extravascular CO-binding site [ 1 l] when he observed 
that rats with virtually 100% HbCO could live on 
dissolved (hyperbaric) 02, but died if CO (not N2) was 
then added. This finding was confirmed by Drabkin et 
al. [12] andGoldbaumetal. [13,14], who foundthat in- 
creasing the HbCO by non-inhalatory means to 80% 
was non-lethal. Supporters of Haldane’s thesis have at- 
tempted to discredit these data, but we believe their ob- 
jections [ 15,161 lack compulsion. While anoxia prior to 
mixing inhaled CO throughout body CO stores [15] 
may have contributed to the cause of death in 
Goldbaum’s control group, it does not explain why his 
experimental group (with levels of 6580% HbCO 
maintained for at least 2 h) failed to succumb. 
Goldbaum’s explanation for his data (the pulmonary 
exhalation of dissolved CO prevents its entry into the 
arterial circulation) was rejected [15], but this was bas- 
ed on an erroneous extrapolation of in vitro kinetic data 
[ 171 (neither the time frame nor the reactant concentra- 
tions match conditions in vivo (see also [18,19])). 
Another report [16] asserted that 70% HbCO was 
always non-lethal because: (i) animals given CO by 
peritoneal infusion survived indefinitely at 70% HbCO; 
and (ii) physiological parameters in anaesthetized 
animals that received CO by inhalation or infusion were 
equivalent for 150 min. The problem is that the max- 
imum %HbCO monitored in the latter pair of ex- 
periments was only 60%. Given these numerical im- 
precisions, it is imperative that HbCO levels of up to 
80% be examed before discarding Goldbaum’s ideas. 
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2. A POSSIBLE DIFFERENCE BETWEEN 
INHALED AND INFUSED CO 
* This paper is respectfully dedicated to the memory of Bonnie Win- 
chell 
Although as yet unproven, Goldbaum’s hypothesis 
does serve as a useful vehicle to introduce the reader to 
some of the basic concepts surrounding current views 
on the mechanism of CO toxicity. A corollary of the 
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hypothesis is that when CO uptake is by inhalation, 
blood in the pulmonary veins will contain more dissolv- 
ed CO (CO not bound to Hb) than when uptake is by in- 
fusion. We will consider a situation in which 80% 
HbCO is attained over the course of several hours by in- 
halation of 0.24% CO in air or by periodic peritoneal 
infusion of 200 ml CO/kg [20]. Based on the %CO in 
the inhaled gas (and given that the amount of dissolved 
CO this is in equilibrium which is readily removed from 
an infused sample during a single passage through the 
lungs), the difference in dissolved CO between inhaled 
and infused samples is 1.98 PM (total dissolved 02 is 
141 PM for both). 
Such a difference in CO levels could arise if during 
exhalation of infused CO there was insufficient time to 
achieve equilibrium between HbCO, dissolved CO and 
gaseous CO. This represents no violation of the laws of 
thermodynamics because it is a kinetic process arising 
from the combination of a relatively rapid passage of 
the erythrocyte through the pulmonary capillary bed 
with a slow release of CO from HbCO, an outwardly 
directed CO gradient and a requirement for Henry’s 
law to be satisfied. When CO is inhaled, equilibrium 
between solution and gas phase CO is more nearly ap- 
proached, but even here equilibration is imperfect 
[21-241. The difference in CO levels could be maintain- 
ed till the capillary beds of the heart and brain were 
reached, if after the blood left the capillary-alveolar in- 
terface there was no dissociation of CO from HbCO. 
Diffusion of CO into a gas phase [25] is impossible and 
given the rate constants for ligation of CO to Hb [6] 
(k&&=0.25 s-‘/2.4x 10’ M-i s-i) plus the short 
time for travel from the pulmonary vein to the coronary 
(< 1 s) or cerebral (3-5 s) arteries [26], there is good 
reason to believe that the CO level will not be changed. 
3. THE R CONSTANT PROBLEM 
But can 2,uM CO bind to cytochrome c oxidase (CcO) 
in vivo, if the intravascular [02] = 141 PM? Proponents 
frequently quote the observation of Chance et al. [27] 
that the response (cytochrome c oxidation) of isolated 
mitochondria to a 17 PM 02 pulse was ‘greatly im- 
paired’ by just 100 ppm of gas phase CO (equivalent o 
82 nM dissolved CO; CO/O2 ratio =0.0048). Aside 
from the fact that the response was not quantitated, the 
experimental protocol itself (preincubation of 
mitochondria with CO followed by addition of 02) 
lessens the force of the finding, since with [CcO] = 275 
nM [28] and & CO = 460 nM [29], 15% of the oxidase 
molecules would be CO-bound prior to the 02 pulse. 
The justification for the opposing viewpoint [30] is 
even less compelling. It has been claimed that since 
tissue CO/O2 ratios are at the most 0.1, an oxidase R 
constant (& CO/& 02 or the CO/O2 ratio at either 
50% ligation or inhibition of function) of 5-15, 
precludes CO inhibiting Cc0 in vivo. This proposition 
has at least three problems associated with it, e.g., the 
possibility of tissue 02 gradients [31]; functional 
anaerobiosis facilitating CO ligation by CcO; and final- 
ly no measurement of the Cc0 & 02 at 37°C. A value 
of 500 PM obtained at - 91°C [32] was influenced by 
concomitant complexation of the active site copper with 
CO, while a calculated value of 0.4 nM at 25°C [29] 
reflects the rapid reduction of bound 02 by reduced 
cytochrome a&u as. The latter is more correctly term- 
ed a K,,, and in the discussion which follows use of this 
parameter to express oxygen affinity implies the 
presence of sufficient reducing equivalents to rapidly 
regenerate species that competently bind 02. 
As the first part of a plan to answer the question pos- 
ed at the start of this section, rapid mixing experiments 
at different CO/O2 ratios would be used to determine 
the initial rate of cytochrome c oxidation in isolated 
murine or canine brain mitochondria, followed by a 
series of steady-state measurements of the 02 consump- 
tion rate and spectral form of cytochromes b, cl, c and 
aa with the various CO/O2 ratios held constant during 
the course of the measurement. Along with appropriate 
controls using 02 alone, studies like these would pro- 
vide an in vitro data base for the in vivo studies to be 
elaborated on shortly. The in vitro experiments will per- 
mit all variables of consequence to be measured, which 
is critical because one of the problems in vivo is deter- 
mining the intracellular 02 and hence the Cc0 Km 02, 
i.e., how does one differentiate a K,,, 02 of 6 /cM with 
an [02] of 10pM from a Km 02 of 0.6pM with an [02] 
of 1 PM? In vitro criteria can be established which will 
permit an in vivo determination, e.g., since Km= 
TN/4ki (TN = turnover number; ki = second-order ate 
constant for the 02 reaction with Cc0 [33]), the Cc0 
kinetic profile (at different initial [OZ] and/or [CcO]) 
during the transition from a constant 02 flux steady- 
state to anaerobiosis can be used. 
4. IN VIVO EVIDENCE OF AN INTRACELLULAR 
EFFECT OF CO 
The brain is a good place to look for in vivo evidence 
of an inhibitory effect of CO on tissue cytochromes, 
since it lacks CO buffers (like myoglobin and cyto- 
chrome P-450). Indeed, it has long been claimed that as 
little as 3-5070 HbCO significantly impairs performance 
of audiovisual discrimination tasks [34]. A more direct 
approach has been to probe the intact cortex with 
reflectance spectrophotometry, and two recent obser- 
vations are of interest. 
The first is that during spontaneous respiration on 
room air supplemented with 5% CO2 a substantial frac- 
tion of reduced Cc0 (20%) was present in Hb-perfused 
cortex [35], which oxidized when the 02 content was in- 
creased to 95%. With the presumption that 5% CO2 
eliminates perfusion effects, it was proposed that in 
vivo there was a subset of enzyme molecules which had 
2 
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a higher K,,, for 02 than found in isolated mitochondria. 
However, it should be remembered that, although the 
level of oxidase reduction during in vitro State 3 respira- 
tion is typically 3-4%, under certain circumstances it 
can be as high as 20% [36,37]. The second finding of 
note concerns the response of the respiratory chain of 
fluorocarbon-perfused brain to inhalation of I-5070 CO 
in 02 [38,39]. Ligation of CO to cytochrome a~, reduc- 
tion of cytochrome b and oxidation of cytochromes cl, 
c and a were reported. The data were interpreted with a 
dual oxidase conformer model, but we have another ex- 
planation. 
The best evidence to date indicates that there is no 
electron flow after ligation of CO to Cc0 (with or 
without CO oxygenation) [40] and thus we have discuss- 
ed previously, the most likely reason for the redox state 
of respiratory chain components other than cytochrome 
a3 is a mitochondrial branching reaction. With respect 
to the terminal cytochrome, when both CO and 02 are 
present he spectral form of the oxidase will be dictated 
by the CO/O2 ratio - a high ratio favors the ferrous car- 
bony1 form, while a low one favors an oxidized species. 
At intermediate ratios, the CO-oxygenating form will 
be present [40-441. Interestingly, the a-band charac- 
teristics of the in vitro, half-reduced, CO-oxygenating 
species [40] (as in the resting enzyme - low intensity 
with a broad maximum at 595-600 nm) are compatible 
with the features of a species which could be present 
during CO exposure in vivo, where the a-band dif- 
ference spectrum of 90% 02 + 1% CO vs 100% 02 is 
essentially flat. The Soret spectrum of the in vitro 
species is unknown, but a related moiety, the aerobic 
CO complex of Nicholls [45], has one which differs lit- 
tle from that of the oxidized enzyme. While it could be 
argued that there is no effect of 1% CO, the level of 
cytochrome b reduction is increased in its presence. We 
do not claim that only CO-oxygenating complexes are 
found under these conditions and in fact more than one 
form of the enzyme is probably present. 
The liquid phase CO/O2 ratio in the in vitro spec- 
troscopy study was 12, but CO oxygenation has been 
observed at a ratio of 3. On the basis of prior studies 
[40-451 and the analysis in sections 5 and 6, we believe 
that it will occur at ratios less than 3, although at pre- 
sent we cannot say what the lower limit is. The in- 
travascular CO/O2 ratio in the in vivo study was 0.008, 
but the intracellular ratio was not determined and is ex- 
pected to be much higher than this (see below). 
5. THE PROBLEM OF IN VIVO CO/O2 RATIOS 
We and others [1,5-8,15-221 believe that both the 
Oz-carrying and 02-delivery capabilities of Hb are 
significantly diminished in the presence of CO, i.e., 
ligation of CO to Hb in vivo perturbs 02 homeostatis to 
such an extent that the concentration of dissolved 02 in 
the intracellular compartment is markedly different 
from that found at the same %HbOz but with no CO 
present. As previously discussed, in vivo tissue po2 
measurements must be interpreted with caution, but 
suffice it to say that with continuum values of 5-40 mm- 
Hg [30] found intracellularly under normoxic condi- 
tions (arterial p02 of 100 mmHg = 141 ,ugM 02) a rapid 
lowering of the 02 concentration occurs when the gas 
diffuses out of the capillary erythrocytes. During simple 
hypoxia, if the supply of reducing equivalents is ade- 
quate, 02 turnover can be maintained by an increase in 
the blood flow. If an ‘02~consumption buffer’ existed, 
then even the effects of superimposed hypotension 
could be temporarily ameliorated, i.e., if hypotension 
reduced the time-dependent 02 concentration by 509r0, 
a recruitment of resting electron transport chains (the 
buffer) could maintain a basal 02 consumption rate of 
200/s by doubling the number of active units and in- 
creasing 02 extraction. The lowest p02 satisfying this 
basal requirement is synonymous with the so-called 
critical pot, i.e., that p02 below which 02 turnover is 
dependent on the poz - the ‘critical threshold’ [46]. 
If CO is present in the inspired gas, the anemia and 
most importantly the left shift of the HbO2 dissociation 
curve make tissue hypoxia worse. Furthermore the 
tissue CO should theoretically continue to increase until 
its free concentration reaches the level dictated by 
Henry’s law. For CO to be a competitor of 02 con- 
sumption by CcO, a set of conditions must exist where 
the intracellular [02] is low enough that ‘significant cell 
damage’ (vide infra) occurs only because the perimito- 
chondrial CO/O2 ratio is high enough for a quantita- 
tive, competitive binding of CO to CcO. If Goldbaum 
is correct, this same degree of hypoxia without CO will 
not seriously affect the cell. 
Fictitious ‘normoxic’ CO/O2 ratios of 0.035 to 0.28 
can be calculated from the intracellular p02 measure- 
ments mentioned previously. However, because of its 
effect on tissue po2 we believe that ratios significantly 
greater than 0.28 will be present during hypoxia induc- 
ed by CO. Proof of this requires accurate in vivo mea- 
surements of intracellular CO/O2 ratios and 02 con- 
centrations which can be obtained using strategies like 
those employed in the in vitro studies, e.g., reflectance 
spectrophotometry would measure spectral and ‘activi- 
ty’ parameters as a function of the intravascular 02 
level with and without CO. Then using the in vitro data 
set, one could compute the effective Km 02, CO/O2 
ratio and [02] and also determine, vis a vis the 
Goldbaum-Haldane controversy, the extent of the 
similarity between hypoxic and carbonmonoxic (both 
inhaled and infused) hypoxia. 
6. THE PR COEFFICIENT 
Table I lists the results of a detailed quantitative 
assessment of our ideas using a series of 02 ‘equili- 
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Table 1 
&lOza cc0 02 CcO. Ozb CcO. 02’ PR cc0 .02 cc0 . co 
1 0.1 0.275 10 0.272 0.272 0.025 0.268 0.007 
2 0.7 0.275 10 0.257 0.257 0.175 0.234 0.041 
3 6.0 0.275 10 0.172 0.171 1.50 0.110 0.165 
4 0.1 0.275 1.0 0.250 0.243 0.25 0.220 0.055 
5 0.7 0.275 1.0 0.162 0.151 1.75 0.100 0.175 
6 6.0 0.275 1.0 0.039 0.038 15.0 0.017 0.258 
7 0.1 2.15 10 2.72 2.71 0.025 2.68 0.07 
8 0.7 2.75 10 2.57 2.51 0.175 2.34 0.41 
9 6.0 2.75 10 1.72 1.60 1.50 1.10 1.65 
10 0.1 2.75 1.0 2.50 0.95 0.25 2.20 0.55 
11 0.7 2.75 1.0 1.62 0.74 1.75 1.00 1.75 
12 6.0 2.75 1.0 0.39 0.29 15.0 0.170 2.58 
&CO cc0 co cc0 . co 
13 0.4 0.275 1.0 0.196 - 
14 0.4 0.275 0.1 0.055 - 
a Except for the PR coefficient all entries in the table are in pM 
b [OZ] or [CO] is the free amount 
‘[02] is the total amount 
brium’ (see section 3) calculations with and without 
CO. The PR coefficient (a normalized ratio of the peri- 
mitrochondrial CO/O2 ratio (P) to the oxidase R value 
(R)) has been used to determine whether CO will bind to 
Cc0 in the presence of Oz. A 50% level of inhibition 
(identical to the ‘lethal threshold’ [46]) has been 
selected as being sufficient to cause ‘significant cell 
damage’ (vide supra). With reservations concerning the 
data of Gothert et al. [47] (CO oxygenation was dis- 
counted), we have lowered the perimitochondrial [CO] 
to 1 ,uM. It has been assumed that the & CO (an 
average of four determinations [29,48-501) has the 
same value (0.4,~M) in vivo as in vitro. Current in vitro 
measurements of the K,,, 02 range from 0.1 to 0.6,uM in 
uncoupled mitochondria [51,52] and from 0.7 to 6 PM 
in coupled mitochondria and intact cells [47,52-541 
(associated critical p02 values of l-20 mmHg). 
Although it is a crude approximation, the effect of a 
transition from normotension to hypotension has been 
modelled by letting the [Oz] represent free and total 
perimitochondrial [02], respectively. The choices of a 
50% inhibition of Cc0 oxido-reductase activity as the 
lethal threshold and the values for various components 
of the PR coefficient, while reasonable, are nonetheless 
somewhat arbitrary. The proposed experimental pro- 
tocl can ascertain the truth or fiction of the estimates. 
Nothing will be said concerning functional conse- 
quences of violating critical or lethal thresholds. This is 
a complicated problem to address, due in part at least to 
the ability of the cell to reset priorities when its energy- 
producing apparatus is stressed. 
We note the following: (i) During ‘hypotensive 
hypoxia’ if the Km 02 is 0.1 ,uM and the [02] = 1 .O PM, 
significant amounts of reduced Cc0 appear only in 
regions of relatively high Cc0 concentration (entry 10; 
4 
entry 11 for Km 02 = 0.7,~M). (ii) If the Km 02 is 0.1 PM, 
there is no significant competition between 1 and 10pM 
02 and 1 PM CO. (iii) If the K,,, 02 is 0.7 PM, entry 5 
shows that 1 PM CO can act as a competitive inhibitor 
of 1 ,uM 02, i.e., without CO there is 59% oxygenation 
while in its presence this decrease to 36% (should 
Gothert [47] be’incorrect, the values would be 59% and 
22%, respectively). (iv) Entries 6 and 12 show a ‘deoxy 
Cc0 effect’ in which non-competitive CO binding oc- 
curs because the K, 02 is so low compared to the Km 02 
(as is true for comparable calculations with Hb, the PR 
coefficient somewhat overestimates %CcO . CO or 
%CcO .Oz when the amount of deoxy-Cc0 is signifi- 
cant). 
These observations can be applied to specific ques- 
tions raised by our discussion as follows: (i) The 
distribution of ‘poisoned’ Cc0 species may vary from 
region to region within a particular organ as well as be- 
ing organ-dependent per se. (ii) The effect of CO is sole- 
ly one of hypoxia if the K,,, 02 is 0.1 FM but the tissue 
02 must decrease to a very low level (0.1 PM) before the 
lethal threshold is crossed. (iii) When the K,,, 02 is 0.7 
PM, an 02 concentration of 1 .O PM is non-lethal unless 
CO is present. This shows that Goldbaum’s hypothesis 
is tenable at the molecular level. (iv) Our analysis in- 
dicates that when Km 02 = 0.7 PM, the mechanism of 
CO toxicity depends on the CO concentration, e.g. 
below 0.4 PM CO (44% HbCO or 58% HbCO if 
Gothert [47] is correct) hypoxia predominates, while 
above this concentration competitive inhibition of 02 
consumption occurs (CO oxygenation can take place 
anytime CO and 02 are present ogether but is most ef- 
ficient when CO is bound to Cc0 prior to 02 [32,44, 
45,551). As the Cc0 K,,, 02 increases, the %HbCO at 
which the transition occurs, diminishes. 
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7. SUMMARY AND CONCLUSIONS 
Our purpose has been not only to question dogma but 
to provide a testable alternative. We have examined the 
chemical-biochemical basis of the two current theories 
and believe that the ideas presented here support the 
alternative hypothesis that the toxicity of CO can be due 
not only to cellular 02 starvation but also to ligation of 
CO by Cc0 (with or without CO oxygenation). Recent 
developments from the laboratories of Chance [56] and 
Jobsis-VanderVleit [57] should facilitate examination 
of Cc0 in the intact, Hb-perfused brain, since further 
investigation is needed if the debate is to be resolved. 
The technique of in vivo reflectance spectrophotometry 
can assess what merit our interpretation of the in vivo 
spectrophotometric studies has and determine more 
precisely the role of CO oxygenation in acute and 
chronic CO poisoning. We have previously presented 
the case for the latter [40] and though preliminary, both 
in vitro [40] and in vivo [58] evidence for the former ex- 
ists, e.g., it appears that the rate of CO oxygenation in 
mitochondria and respiring humans is much faster than 
in the isolated enzyme (2/min per aas). 
In closing, we would like to mention several medical 
implications of our hypothesis. We assert that the 
%HbCO remains the single most accurate and reliable 
indicator of the severity of acute inhalation of CO. Car- 
bon monoxide is a toxic gas and, although it can be 
metabolized by man, this is done so at a cost, e.g., 
paresis of ATP production. Therefore, currently man- 
dated environmental evels of exposure should not be 
tampered with. Finally, it seems fair to state that, 
whatever future experimentation tells us about the 
precise mechanisms of CO toxicity, the current treat- 
ment of severe acute exogenous CO poisoning (controll- 
ed ventilation with hyperbaric 0~) could be improved 
by incorporating exchange transfusions with 02-satu- 
rated blood. 
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